2,6-二氯-4-氯甲基吡啶 | 101990-72-1

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2,6-二氯-4-氯甲基吡啶
• 英文名称: 2,6-dichloro-pyridin-4-ylmethyl chloride
• 英文别名: 2,6-dichloro-4-(chloromethyl)pyridine；2,6-dichloro-4-chloromethylpyridine；2,6-dichloroisonicotinyl chloride；2,6-dichloro-4-chloromethyl-pyridine；2,6-dichloro-isonicotinyl chloride
• CAS: 101990-72-1
• 化学式: C₆H₄Cl₃N
• mdl: MFCD03783562
• 分子量: 196.463
• InChiKey: UYBVOPLURVHJOX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.166
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xn,C
• 危险类别码：
  R22,R34
• 安全说明：
  S26,S36/37/39,S45
• 海关编码：
  2933399090

SDS

Name:	2 6-Dichloro-4-(chloromethyl)pyridine tech Material Safety Data Sheet
Synonym:
CAS:	101990-72-1

Section 1 - Chemical Product MSDS Name:2 6-Dichloro-4-(chloromethyl)pyridine tech Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
101990-72-1	2,6-Dichloro-4-(chloromethyl)pyridine		unlisted

Hazard Symbols: C
Risk Phrases: 22 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful if swallowed. Causes burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Harmful if swallowed. Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 101990-72-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C6H4Cl3N
Molecular Weight: 196.46

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 101990-72-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,6-Dichloro-4-(chloromethyl)pyridine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, TOXIC, N.O.S.*
Hazard Class: 8 (6.1)
UN Number: 2923
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, TOXIC, N.O.S.
Hazard Class: 8 (6.1)
UN Number: 2923
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, TOXIC, N.O.S.
Hazard Class: 8 (6.1)
UN Number: 2923
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 22 Harmful if swallowed.
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 101990-72-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 101990-72-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 101990-72-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2,6-二氯-4-氯甲基吡啶 以 乙醇 为溶剂， 生成 2,6-二氯异烟酸乙酯
  参考文献：
  名称：

  Method for protecting plants against diseases

  摘要：

  一种用于对健康植物进行免疫防治植物疾病的方法，该方法包括通过使用以下式的活性成分来处理和/或包覆种子或处理植物和/或它们的环境： 其中Hal是卤素，X是氧或硫，R是氢，C.sub.1 -C.sub.6 -烷基，C.sub.1 -C.sub.6 -烷基，被氧或硫原子中断，C.sub.1 -C.sub.6 -烷基，被卤素、氰基或COO--C.sub.1 -C.sub.6 -烷基基团取代，未取代或被卤素取代的C.sub.3 -C.sub.5 -烯烃基，未取代或被卤素取代的C.sub.3 -C.sub.5 -炔烃基，未取代或被卤素或甲基取代的C.sub.3 -C.sub.6 -环烷基，或者是由碱或碱性化合物形成的阳离子的正常当量。

  公开号：

  US04968344A1
• 作为产物：
  描述：

  2,6-二氯吡啶-4-甲醇 在 吡啶 、 氯化亚砜 、 sodium sulfate 作用下， 以 乙醚 、 水 、 甲苯 为溶剂， 生成 2,6-二氯-4-氯甲基吡啶
  参考文献：
  名称：

  2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals

  摘要：

  本发明的目的是提供一种新型化合物，该化合物对作物植物具有很小的植物毒性可能性，并且在控制由病毒、细菌和霉菌引起的各种植物疾病方面具有极大的有效性，并提供含有此化合物2,6-二氯-4-吡啶甲醇和/或其苯甲酸酯作为活性成分的农药化学品，特别是用于控制植物疾病的药剂。为了实现这一目的，提供了2,6-二氯-4-吡啶甲醇衍生物、2,6-二氯-4-吡啶甲醇、其苯甲酸酯以及含有这些化合物作为活性成分的农药化学品，其中2,6-二氯-4-吡啶甲醇衍生物由通式（1）表示：其中W表示可选取代的C1至C8烷基、三氟甲基吡啶基、—COR1、—SO2R2、—PO（OR3）2、—CONHR4、—COOR4、—COCOR4或—SiR5R6R7，其中：R1表示可选取代的C1至C18烷基、可选取代的C1至C18烯基、具有一个或多个特定取代基的苯基或具有氮原子、氧原子或硫原子中的任一种作为环组分原子的5-或6-成员杂环环残基；R2表示烷基或苯基；R3表示烷基；R4表示烷基或苯基；且R5至R7中的每一个表示烷基。

  公开号：

  US06281231B1

文献信息

• [EN] 6-(MORPHOLIN-4-YL)-PYRIDIN-2-YL-1H-PYRROLO[3,2-B]PYRIDINE DERIVATIVES AS M-TOR INHIBITORS<br/>[FR] DÉRIVÉS DE 6-(MORPHOLIN-4-YL)-PYRIDIN-2-YL-1H-PYRROLO[3,2-B]PYRIDINE EN TANT QU'INHIBITEURS DE M-TOR
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2019115640A1

  公开（公告）日：2019-06-20

  The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, L and A are as defined in the description and claims, or pharmaceutically acceptable salts thereof having mTOR kinase inhibitor activity. The invention also relates to pharmaceutical compositions including a compound of formula (I) or a pharmaceutically acceptable salt thereof, and to the use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in therapy, including in the treatment of a disease or condition for which an mTOR kinase inhibitor activity is indicated, and in particular the treatment of idiopathic pulmonary fibrosis.

  该发明涉及式(I)的化合物，其中R1、R2、R3、R4、L和A如描述和索赔中所定义，或其药学上可接受的盐，具有mTOR激酶抑制剂活性。该发明还涉及包括式(I)的化合物或其药学上可接受的盐的药物组合物，以及在治疗中使用式(I)的化合物或其药学上可接受的盐，包括治疗需要mTOR激酶抑制剂活性的疾病或症状，特别是治疗特发性肺纤维化。
• [EN] PYRIDYL OR PYRIMIDYL MTOR KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE MTOR DE PYRIDYLE OU DE PYRIMIDYLE
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2020249652A1

  公开（公告）日：2020-12-17

  The invention relates to compounds or pharmaceutically acceptable salts thereof of formula (I): (I) wherein R1, R2, R3, R4, R4' and R5 are as defined in the description and claims; and compounds or pharmaceutically acceptable salts thereof of formulas (II), (IIa), (IIb), (IIc), and (III) having mTOR kinase inhibitor activity. The invention also relates to pharmaceutical compositions which include a compound of formula (I), (II), (IIa), (IIb), (IIc), or (III) or a pharmaceutically acceptable salt thereof, and to the use of a compound of formula (I), (II), (IIa), (IIb), (IIc), or (III), or a pharmaceutically acceptable salt thereof in therapy, including in the treatment of a disease or condition for which an mTOR kinase inhibitor activity is indicated, and in particular the treatment of idiopathic pulmonary fibrosis.

  该发明涉及化合物或其药用可接受盐的公式(I)：（I）其中R1、R2、R3、R4、R4'和R5如描述和索赔中定义；以及具有mTOR激酶抑制剂活性的公式(II)、(IIa)、(IIb)、(IIc)和(III)的化合物或其药用可接受盐。该发明还涉及包括公式(I)、(II)、(IIa)、(IIb)、(IIc)或(III)的化合物或其药用可接受盐的药物组合物，以及在治疗中使用公式(I)、(II)、(IIa)、(IIb)、(IIc)或(III)的化合物或其药用可接受盐，包括治疗需要mTOR激酶抑制剂活性的疾病或症状，特别是治疗特发性肺纤维化。
• [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
  申请人：GLAXO GROUP LTD

  公开号：WO2012035055A1

  公开（公告）日：2012-03-22

  The invention is directed to certain novel compounds. Specifically, the invention directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular Itk activity.

  这项发明涉及某些新颖的化合物。具体地，该发明涉及公式（I）的化合物及其盐。该发明的化合物是激酶活性抑制剂，特别是Itk活性的抑制剂。
• [EN] DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES<br/>[FR] DÉRIVÉS DE 2-[2-(BENZO- OU PYRIDO-)THIAZOLYLAMINO]-6- AMINOPYRIDINE, UTILES DANS LE TRAITEMENT DE MALADIES RESPIRATOIRES, ALLERGIQUES OU INFLAMMATOIRES
  申请人：GLAXO GROUP LTD

  公开号：WO2011110575A1

  公开（公告）日：2011-09-15

  The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular Itk activity.

  本发明涉及某些新型化合物。具体而言，本发明涉及通式（I）的化合物及其盐。本发明的化合物是激酶活性的抑制剂，特别是Itk活性的抑制剂。
• Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
  申请人：AVENTIS PHARMA S.A.

  公开号：US20040248884A1

  公开（公告）日：2004-12-09

  The present invention relates to a cyclic urea compound of formula I: 1 as defined herein. The invention is also directed to the process for its preparation, pharmaceutical composition comprising it and its pharmaceutical use, as an inhibitor on a protein kinase. Thus, it is useful for preventing or treating a physiological disorder capable of being modulated by inhibiting the activity of a protein kinase, such as a solid tumor.

  本发明涉及一种如下式的环脲化合物： 1 如本文所定义。该发明还涉及其制备方法，包括它的药物组合物以及其作为蛋白激酶抑制剂的药用，因此，它对于预防或治疗能够通过抑制蛋白激酶活性而调节的生理紊乱是有用的，比如固体肿瘤。